Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Census population 211,328. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Rochester clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Rochester storefront.
Sports Recovery Treatment Options in Rochester, NY for clinics & physicians. Accelerate sports recovery wi… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Obesity 38%; arthritis 24.9%. Those three PLACES crude rates (plus Census 211,328) are the local facts on this page. Everything else is the national sports recovery treatments catalog and JK paperwork.
National Sports Recovery Treatment Options notes (how the product actually works)Three grains, kept separate on purpose. City: Census 211,328 and CDC PLACES crude rates. State: New York State Department of Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and National Government Services (NGS) LCDs. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Rochester trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 14.3% of adults — 2.3 points above the U.S. 12% figure. Obesity is 38%; arthritis is 24.9%. That is place-level BRFSS modeling, not a clinic census and not a Rochester trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a New York compliance risk.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
Bring specialty, monthly joint / regenerative volume, and whether you bill JK FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 14.3% diabetes and 24.9% arthritis for Rochester — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Rochester, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Rochester is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Rochester — 2.3 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Rochester. Useful for joint-program math; still needs a diagnosis and privileging.
No Rochester storefront. Joe Bradley is an active practice owner. sports recovery treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.